5N-dimethyl-N-isopropyltryptamine (5-Me-MiPT) is a tryptamine derivative that is thought to be a psychedelic drug. It was first made in 1989. In vitro binding experiments on brain homogenates showed it to have a binding affinity between that of MiPT and 5-MeO-MiPT both of which are known to be active psychedelics in humans.
